# to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers

> **NCT02289430** · PHASE1 · COMPLETED · sponsor: **NVP Healthcare** · enrollment: 59 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Crestor+Ezetrol
- **DRUG:** Ezetrol
- **DRUG:** Crestor

## Key facts

- **NCT ID:** NCT02289430
- **Lead sponsor:** NVP Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2016-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02289430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02289430, "to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02289430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*